Joilton
Lutterbach’s
Ultimate Fighting Championship tenure has ended before he was
able to set foot into the Octagon.
Advertisement
On Tuesday, Combat Sports Anti-Doping (CSAD) announced that Lutterbach tested positive for a
metabolite of the anabolic steroid drostanolone in an
out-of-competition sample collected on June 8. That test occurred
two weeks before Lutterbach was scheduled to face Sharabutdin
Magomedov at
UFC on ABC 6 in Saudi Arabia.
Lutterbach was notified of his positive test on June 20 at the
fighter hotel in Saudi Arabia, where he admitted use of the banned
substance. Because he did not declare the use of drostanolone
before being tested, he received a two-year suspension from CSAD.
Additionally, the UFC has terminated his contract with the
promotion. Lutterbach will be eligible to return to active
competition on June 23, 2026.
“I actually used juice [three] months ago and had no idea I would
sign with the UFC,” Lutterbach wrote on Instagram on June 20. I could have hidden in the
mountains or gone to Thailand to hide as many do and are not
tested, but I preferred to take the risk and believe I was clean
and fit to fight.”
The 31-year-old Brazilian owns a 38-9 professional record with one
no contest. He has competed for organizations such as Brave Combat
Federation, Professional Fighters League, Cage Warriors, KSW and
M-1 Global, to name a few.